Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uday Popat

Showing results (21-30 of 262) with videos related to

Pageof 27
Sort By:
American Journal of Hematology|June 25, 2010
The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypesManish Sharma, Sofia R Qureshi, Richard E Champlin, et al.
Blood|January 19, 2006
High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertensionUday Popat, Adaani Frost, Enli Liu, et al.
Annals of Internal Medicine|September 21, 2005
New onset of myelofibrosis in association with pulmonary arterial hypertensionUday Popat, Adaani Frost, Enli Liu, et al.
Hematology/Oncology and Stem Cell Therapy|February 8, 2018
Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantationAron Simkins, Abhishek Maiti, Nicholas J Short, et al.
Leukemia|May 2, 2024
Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxisJeremy Ramdial, Partow Kebriaei, Richard E Champlin, et al.
Blood Advances|September 30, 2021
Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide eraJason Yeh, Laura Whited, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?Daniel Couriel, Chitra Hosing, Rima Saliba, et al.
Blood Advances|August 21, 2024
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerationsRohtesh S Mehta, Jeremy Ramdial, Partow Kebriaei, et al.
Oncotarget|March 14, 2024
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cellsBenigno C Valdez, Bin Yuan, David Murray, et al.
Experimental Hematology|August 14, 2018
Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cellsBenigno C Valdez, Xiaowen Tang, Yang Li, et al.
Pageof 27

Showing results (21-30 of 262) with videos related to

Sort By:
Pageof 27
American Journal of Hematology|June 25, 2010
The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypesManish Sharma, Sofia R Qureshi, Richard E Champlin, et al.
Blood|January 19, 2006
High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertensionUday Popat, Adaani Frost, Enli Liu, et al.
Annals of Internal Medicine|September 21, 2005
New onset of myelofibrosis in association with pulmonary arterial hypertensionUday Popat, Adaani Frost, Enli Liu, et al.
Hematology/Oncology and Stem Cell Therapy|February 8, 2018
Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantationAron Simkins, Abhishek Maiti, Nicholas J Short, et al.
Leukemia|May 2, 2024
Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxisJeremy Ramdial, Partow Kebriaei, Richard E Champlin, et al.
Blood Advances|September 30, 2021
Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide eraJason Yeh, Laura Whited, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?Daniel Couriel, Chitra Hosing, Rima Saliba, et al.
Blood Advances|August 21, 2024
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerationsRohtesh S Mehta, Jeremy Ramdial, Partow Kebriaei, et al.
Oncotarget|March 14, 2024
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cellsBenigno C Valdez, Bin Yuan, David Murray, et al.
Experimental Hematology|August 14, 2018
Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cellsBenigno C Valdez, Xiaowen Tang, Yang Li, et al.
Pageof 27